These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8993515)

  • 1. Camptothecin and its analogs. An overview of their potential in cancer therapeutics.
    Muggia FM; Dimery I; Arbuck SG
    Ann N Y Acad Sci; 1996 Dec; 803():213-23. PubMed ID: 8993515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The camptothecins.
    Pizzolato JF; Saltz LB
    Lancet; 2003 Jun; 361(9376):2235-42. PubMed ID: 12842380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of irinotecan in lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Irinotecan].
    Yokoyama A
    Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical and clinical trials of topoisomerase inhibitors.
    Saijo N
    Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of CPT-11 in Japan.
    Taguchi T
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():277-83. PubMed ID: 7661595
    [No Abstract]   [Full Text] [Related]  

  • 7. [Irinotecan hydrochloride (CPT-11)].
    Furue H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinotecan in lymphoma, leukemia, and breast, pancreatic, ovarian, and small-cell lung cancers.
    Rosen LS
    Oncology (Williston Park); 1998 Aug; 12(8 Suppl 6):103-9. PubMed ID: 9726101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topoisomerase I inhibitors. An overview of the camptothecin analogs.
    Burris HA; Fields SM
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):333-55. PubMed ID: 8040144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
    Garcia-Carbonero R; Supko JG
    Clin Cancer Res; 2002 Mar; 8(3):641-61. PubMed ID: 11895891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on camptothecins in cancer treatment.
    Dancey J; Eisenhauer EA
    Br J Cancer; 1996 Aug; 74(3):327-38. PubMed ID: 8695345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan: summary and future directions.
    Johnson DH
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):46-7. PubMed ID: 11221021
    [No Abstract]   [Full Text] [Related]  

  • 13. [DNA topoisomerase inhibitor].
    Sugiura T; Ariyoshi Y
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2140-5. PubMed ID: 1332623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer.
    Negoro S; Fukuoka M; Masuda N; Takada M; Kusunoki Y; Matsui K; Takifuji N; Kudoh S; Niitani H; Taguchi T
    J Natl Cancer Inst; 1991 Aug; 83(16):1164-8. PubMed ID: 1653362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New directions for chemotherapy in non-small-cell lung cancer.
    Green MR
    Chest; 1993 Apr; 103(4 Suppl):370S-372S. PubMed ID: 8096453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
    Kumazawa E; Jimbo T; Ochi Y; Tohgo A
    Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of irinotecan in the treatment of small cell carcinoma].
    Crinò L
    Tumori; 2001; 87(6):A35-7. PubMed ID: 11995707
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical applications of the camptothecins.
    Takimoto CH; Wright J; Arbuck SG
    Biochim Biophys Acta; 1998 Oct; 1400(1-3):107-19. PubMed ID: 9748525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The other camptothecins: recent advances with camptothecin analogues other than irinotecan and topotecan].
    Lavergne O; Bigg DC
    Bull Cancer; 1998 Dec; Spec No():51-8. PubMed ID: 9932086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent antitumor activity and improved pharmacological profile of ST1481, a novel 7-substituted camptothecin.
    De Cesare M; Pratesi G; Perego P; Carenini N; Tinelli S; Merlini L; Penco S; Pisano C; Bucci F; Vesci L; Pace S; Capocasa F; Carminati P; Zunino F
    Cancer Res; 2001 Oct; 61(19):7189-95. PubMed ID: 11585754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.